Experience with the once-yearly histrelin (GnRHa) subcutaneous implant in the treatment of central precocious puberty
Katherine A Lewis, Erica A EugsterDepartment of Pediatrics, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, USAAbstract: In 2007, a hydrogel histrelin implant was approved for the treatment of children with central precocious puberty (CPP). Children with CPP commonl...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2008-12-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | http://www.dovepress.com/experience-with-the-once-yearly-histrelin-gnrha-subcutaneous-implant-i-a2752 |